Supernus Pharmaceuticals | SUPN - Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
Abbott USD 5.94B 642M 2026-06
ANI Pharmaceuticals USD 114.5M 8.38M 2026-03
Aurora Cannabis CAD 8.22M 80.38M 2026-03
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Canopy Growth CAD 62.98M 9.91M 2026-03
Cara Therapeutics USD 0 0 2025-03
Corcept Therapeutics USD 4.06M 1.18M 2026-06
Eisai JPY 51.09B 926M 2026-06
Eli Lilly USD 3.27B 309M 2026-06
Novo Nordisk DKK 17.1B 3.5B 2026-06
Pacira USD 58.49M 7.75M 2026-06
Perrigo USD 708.9M 65.2M 2026-06
Pfizer USD 4.09B 498M 2026-06
Supernus Pharmaceuticals USD 59M 9.97M 2026-06
United Therapeutics USD 99.5M 33.9M 2026-06
Xeris Pharmaceuticals USD 10.57M 3.08M 2026-03